title: Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection.
authors.affiliation: aDepartment of Internal Medicine and Infectious DiseasesbDepartment of Hospital Pharmacy, Erasmus Medical Center, RotterdamcDepartment of Internal Medicine and Medical Microbiology, Maastricht University Medical Center, MaastrichtdDepartment of Internal Medicine and Infectious DiseaseseDepartment of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands.
authors.forename: Sebastiaan J
authors.initials: SJ
authors.lastname: Hullegie
authors.forename: Brenda C M
authors.initials: BC
authors.lastname: de Winter
authors.forename: Dirk
authors.initials: D
authors.lastname: Posthouwer
authors.forename: Peter P
authors.initials: PP
authors.lastname: Koopmans
authors.forename: Mark A A
authors.initials: MA
authors.lastname: Claassen
authors.forename: David M
authors.initials: DM
authors.lastname: Burger
authors.forename: Bart J A
authors.initials: BJ
authors.lastname: Rijnders
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009426:Netherlands; D010949:Plasma / Q000737:chemistry; D011392:Proline / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000068696:Rilpivirine / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D000998:Antiviral Agents; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline; D000068696:Rilpivirine